Atria Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,666
Closed -$695K – 2138
2026
Q2
$695K Sell
3,666
-240
-6% -$35.6K 0.01% 1325
2026
Q1
$364K Buy
+3,906
New +$346K ﹤0.01% 1630

Other funds holding ACLS

Atria Investments's ACLS Position: Q3 2026 in Review

Atria Investments sold out of Axcelis (ACLS) in Q3 2026, closing a stake of 3,666 shares — an estimated $695K sold.

Atria Investments first reported a position in ACLS in Q1 2026 and held it in 2 quarters. The position peaked at $695K in Q2 2026. 23 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Atria Investments reported no remaining Axcelis position as of Q3 2026 after selling out during the quarter.
  • Atria Investments sold 3,666 Axcelis shares in Q3 2026, an estimated $695K.
  • Atria Investments first reported a position in Axcelis in Q1 2026 and held it in 2 quarters.
  • Atria Investments's Axcelis position peaked at $695K in Q2 2026.
  • 23 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Atria Investments's 13F filing for Q3 2026, filed 15 Oct 2026.